| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Expression profiling by high throughput sequencing
|
RESULTS
|
Hongjian Jin
|
|||||
| GSE240505 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [RNA-seq]
|
|
22 |
|
Hongjian Jin | Mar 04, 2024 | ||
| GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
26 |
|
Hongjian Jin | Mar 02, 2024 | ||
| GSE240980 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
|
8 |
|
Hongjian Jin | Jun 26, 2024 | ||
| GSE245161 |
Gene expression profile of Duocarmycin SA-treated human AML cell lines in vitro
|
|
12 |
|
Hongjian Jin | May 01, 2024 | ||
| GSE248283 |
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor
|
|
12 |
|
Hongjian Jin | Mar 11, 2024 | ||
| GSE253185 |
Credentialling a c-MYC-driven genetic neuroblastoma model
|
|
5 |
|
Hongjian Jin | Nov 05, 2024 | ||
| GSE255205 |
Credentialling a c-MYC-driven genetic neuroblastoma model [RNAseq-NB]
|
|
14 |
|
Hongjian Jin | Nov 05, 2024 |
